| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3900429 | Urology | 2013 | 8 Pages |
Abstract
The present results have indicated that imatinib has significant erectile and systemic vasodilator activity in the rat that is not dependent on nitric oxide release. Another tyrosine kinase inhibitor, nilotinib, also increased the ICP and decreased the MAP in the rat. These data suggest that tyrosine kinases might play a constitutive role in maintaining penile tumescence and the baseline vasoconstrictor tone in the peripheral vascular bed.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Edward A. Pankey, George F. Lasker, Serap Gur, Wayne J.G. Hellstrom, Philip J. Kadowitz,